The University of Hong Kong-Shenzhen Hospital is a public hospital in Futian District, Shenzhen, Guangdong, China. The 600 bed hospital is one of the two teaching hospitals of The University of Hong Kong, and the Shenzhen municipal government constructed and provided funding for the facility.

During the past decade, The University of Hong Kong-Shenzhen Hospital conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 8 clinical trials were completed, i.e. on average, 24.2% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 8 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The University of Hong Kong-Shenzhen Hospital" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Pfizer" with 5 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Reistone Biopharma Company Limited" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The University of Hong Kong-Shenzhen Hospital" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Daiichi Sankyo (China) Holdings Co., Ltd." with 1 trials as a collaborator and "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "The University of Hong Kong-Shenzhen Hospital" are "Dermatitis, Atopic" (3 trials), "Ulcerative Colitis" (3 trials), "Alopecia Areata" (2 trials), "Crohn's Disease" (2 trials) and "Migraine" (2 trials). Many other conditions were trialed in "The University of Hong Kong-Shenzhen Hospital" in a lesser frequency.

Most popular intervention types in "The University of Hong Kong-Shenzhen Hospital" are "Drug" (25 trials), "Device" (3 trials), "Other" (3 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Atezolizumab" (3 trials), "Atezolizumab Matching Placebo" (2 trials), "Blood sample" (2 trials) and "Data collection" (2 trials). Other intervention names were less common.

The vast majority of trials in "The University of Hong Kong-Shenzhen Hospital" are 33 trials for "All" genders.

Currently, there are NaN active trials in "The University of Hong Kong-Shenzhen Hospital". undefined are not yet recruiting, 4 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in The University of Hong Kong-Shenzhen Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The University of Hong Kong-Shenzhen Hospital, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".